Literature DB >> 25640353

Epidemiological trends of histopathologically WHO classified CNS tumors in developing countries: systematic review.

Ishaq Khan1, Mohammed Bangash, Saleh Baeesa, Awatif Jamal, Angel Carracedo, Fahad Alghamdi, Hanadi Qashqari, Adel Abuzenadah, Mohammed AlQahtani, Ghazi Damanhouri, Adeel Chaudhary, Deema Hussein.   

Abstract

BACKGROUND: Many developing countries are lagging behind in reporting epidemiological data for individual central nervous system (CNS) tumors. This paper aimed to elicit patterns for the epidemiology of individual World Health Organization (WHO) classified CNS tumors in countries registered by WHO as "developing".
MATERIALS AND METHODS: Cyber search was carried out through 66 cancer networks/registries and 181 PubMed published papers that reported counts of CNS tumors for the period of 2009-2012. The relationship between the natural log of incidence Age Standardized Rate (ASR) reported by Globocan and Latitude/ Longitude was investigated.
RESULTS: Registries for 21 countries displayed information related to CNS tumors. In contrast tends for classified CNS tumor cases were identified for 38 countries via 181 PubMed publications. Extracted data showed a majority of unclassified reported cases [PubMed (38 countries, 45.7%), registries (21 countries, 96.1%)]. For classified tumors, astrocytic tumors were the most frequently reported type [PubMed (38 countries, 1,245 cases, 15.7%), registries (21 countries, 627 cases, 1.99%]. A significant linear regression relationship emerged between latitudes and reported cases of CNS tumors.
CONCLUSIONS: Previously unreported trends of frequencies for individually classified CNS tumors were elucidated and a possible link of CNS tumors occurrence with geographical location emerged.

Entities:  

Mesh:

Year:  2015        PMID: 25640353     DOI: 10.7314/apjcp.2015.16.1.205

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Overlapping variants in the blood, tissues and cell lines for patients with intracranial meningiomas are predominant in stem cell-related genes.

Authors:  Deema Hussein; Ashraf Dallol; Rita Quintas; Hans-Juergen Schulten; Mona Alomari; Saleh Baeesa; Mohammed Bangash; Fahad Alghamdi; Ishaq Khan; M-Zaki Mustafa ElAssouli; Mohamad Saka; Angel Carracedo; Adeel Chaudhary; Adel Abuzenadah
Journal:  Heliyon       Date:  2020-11-30

2.  Histopathological Analysis of Brain Tumours- A Seven Year Study from a Tertiary Care Centre in South India.

Authors:  Renu Thambi; Subitha Kandamuthan; Sheeja Sainulabdeen; Letha Vilasiniamma; Tinu Ravi Abraham; P K Balakrishnan
Journal:  J Clin Diagn Res       Date:  2017-06-01

3.  Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.

Authors:  Ishaq Khan; Saleh Baeesa; Mohammed Bangash; Hans-Juergen Schulten; Fahad Alghamdi; Hanadi Qashqari; Nawal Madkhali; Angel Carracedo; Mohamad Saka; Awatif Jamal; Jaudah Al-Maghrabi; Mohammed AlQahtani; Saleh Al-Karim; Ghazi Damanhouri; Kulvinder Saini; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2017-07-21       Impact factor: 5.722

4.  In situ characterization of stem cells-like biomarkers in meningiomas.

Authors:  Hanin Alamir; Mona Alomari; Abdulla Ahmed A Salwati; Mohamad Saka; Mohammed Bangash; Saleh Baeesa; Fahad Alghamdi; Angel Carracedo; Hans-Juergen Schulten; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2018-05-25       Impact factor: 5.722

5.  The Epidemiology of Primary Central Nervous System Tumors at the National Neurologic Institute in Saudi Arabia: A Ten-Year Single-Institution Study.

Authors:  Amna Almutrafi; Yara Bashawry; Wafaa AlShakweer; Musa Al-Harbi; Abdullah Altwairgi; Sadeq Al-Dandan
Journal:  J Cancer Epidemiol       Date:  2020-02-15

6.  Incidence of Gliomas in Municipalities of Zenica - Doboj Canton in Bosnia and Herzegovina - A 10-Year Study.

Authors:  Nadija Ekinovic; Hakija Beculic; Rasim Skomorac; Aldin Jusic; Anes Masovic; Damir Kurtagic; Nedim Barucija
Journal:  Medeni Med J       Date:  2020-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.